Literature DB >> 28887838

Diagnostic accuracy of optical coherence tomography inter-eye percentage difference for optic neuritis in multiple sclerosis.

D Coric1,2, L J Balk1,2, B M J Uitdehaag1, A Petzold1,2,3,4,5.   

Abstract

BACKGROUND AND
PURPOSE: Multiple sclerosis-associated optic neuritis (MSON) causes atrophy of the inner retinal layers, which can be quantified by optical coherence tomography. It has been suggested that the inter-eye percentage difference (IEPD) of atrophy may be of diagnostic value in MSON.
METHODS: This was a prospective, cross-sectional study in patients with multiple sclerosis and healthy controls (HCs). Spectral-domain optical coherence tomography of both eyes was performed, followed by automated retinal layer segmentation of the peri-papillary retinal nerve fibre layer (pRNFL) and macular ganglion cell and inner plexiform layer (mGCIPL). Receiver operator characteristics curves were plotted and the area under the curve was calculated for group comparisons of the IEPD of the pRNFL and mGCIPL.
RESULTS: There were 39 patients with bilateral MSON, 62 patients with unilateral MSON, 106 patients without MSON and 63 HCs. Diagnostic accuracy (area under the curve) of the IEPD was 0.73-0.86 for the pRNFL and 0.75-0.94 for the mGCIPL. The diagnostic sensitivity of the mGCIPL IEPD was 70% with a specificity of 97% for distinguishing unilateral MSON from HCs. For the comparison of bilateral MSON with HCs, sensitivity was 86% with a specificity of 97%.
CONCLUSIONS: The IEPD of the pRNFL, and more particularly the IEPD of the mGCIPL, is a useful diagnostic measure for MSON. The IEPD is a dimensionless unit and may therefore contribute to overcome device and proprietary segmentation algorithm limitations.
© 2017 EAN.

Entities:  

Keywords:  diagnostic criteria; multiple sclerosis; optic neuritis; optical coherence tomography

Mesh:

Year:  2017        PMID: 28887838     DOI: 10.1111/ene.13443

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  15 in total

Review 1.  Optical coherence tomography in multiple sclerosis.

Authors:  Josefine Britze; Jette Lautrup Frederiksen
Journal:  Eye (Lond)       Date:  2018-02-02       Impact factor: 3.775

Review 2.  What Does Optical Coherence Tomography Offer for Evaluating Physical Disability in Patients with Multiple Sclerosis?

Authors:  Ziya Ayhan; Aylin Yaman
Journal:  Noro Psikiyatr Ars       Date:  2018       Impact factor: 1.339

3.  Posterior segment spectral domain oct in the differential diagnosis of bilateral temporal optic neuropathy and its correlation with visual acuity.

Authors:  Tom Buelens; Jean-François Fils; François Willermain
Journal:  Int Ophthalmol       Date:  2022-07-09       Impact factor: 2.031

4.  The Role of Optical Coherence Tomography Criteria and Machine Learning in Multiple Sclerosis and Optic Neuritis Diagnosis.

Authors:  Rachel C Kenney; Mengling Liu; Lisena Hasanaj; Binu Joseph; Abdullah Abu Al-Hassan; Lisanne J Balk; Raed Behbehani; Alexander Brandt; Peter A Calabresi; Elliot Frohman; Teresa C Frohman; Joachim Havla; Bernhard Hemmer; Hong Jiang; Benjamin Knier; Thomas Korn; Letizia Leocani; Elena Hernandez Martinez-Lapiscina; Athina Papadopoulou; Friedemann Paul; Axel Petzold; Marco Pisa; Pablo Villoslada; Hanna Zimmermann; Lorna E Thorpe; Hiroshi Ishikawa; Joel S Schuman; Gadi Wollstein; Yu Chen; Shiv Saidha; Steven Galetta; Laura J Balcer
Journal:  Neurology       Date:  2022-06-28       Impact factor: 11.800

5.  Focal alteration of the intraretinal layers in neurodegenerative disorders.

Authors:  Shriya Airen; Ce Shi; Zhiping Liu; Bonnie E Levin; Joseph F Signorile; Jianhua Wang; Hong Jiang
Journal:  Ann Eye Sci       Date:  2020-03

Review 6.  Pharmacotherapy in Secondary Progressive Multiple Sclerosis: An Overview.

Authors:  Floriana De Angelis; Domenico Plantone; Jeremy Chataway
Journal:  CNS Drugs       Date:  2018-06       Impact factor: 5.749

Review 7.  The International Multiple Sclerosis Visual System Consortium: Advancing Visual System Research in Multiple Sclerosis.

Authors:  Laura J Balcer; Lisanne J Balk; Alexander U Brandt; Peter A Calabresi; Elena H Martinez-Lapiscina; Rachel C Nolan; Friedemann Paul; Axel Petzold; Shiv Saidha
Journal:  J Neuroophthalmol       Date:  2018-12       Impact factor: 3.042

8.  OCT Variability Prevents Their Use as Robust Biomarkers in Multiple Sclerosis.

Authors:  Marta Para-Prieto; Raul Martin; Sara Crespo; Laura Mena-Garcia; Andres Valisena; Lisandro Cordero; Gloria Gonzalez Fernandez; Juan F Arenillas; Nieves Tellez; Jose Carlos Pastor
Journal:  Clin Ophthalmol       Date:  2021-05-14

Review 9.  Advances in ophthalmic structural and functional measures in multiple sclerosis: do the potential ocular biomarkers meet the unmet needs?

Authors:  Hong Jiang; Silvia Delgado; Jianhua Wang
Journal:  Curr Opin Neurol       Date:  2021-02-01       Impact factor: 6.283

Review 10.  Artificial intelligence extension of the OSCAR-IB criteria.

Authors:  Axel Petzold; Philipp Albrecht; Laura Balcer; Erik Bekkers; Alexander U Brandt; Peter A Calabresi; Orla Galvin Deborah; Jennifer S Graves; Ari Green; Pearse A Keane; Jenny A Nij Bijvank; Josemir W Sander; Friedemann Paul; Shiv Saidha; Pablo Villoslada; Siegfried K Wagner; E Ann Yeh
Journal:  Ann Clin Transl Neurol       Date:  2021-05-19       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.